Olink®Part of Thermo Fisher Scientific
Capture true biological insights with proven specificity. At any scale.
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 1,800 and growing rapidly – covering all major disease areas
Help shape the future of health research with Olink’s cutting-edge technology
Filters
Brain Communications, 2023Association between serum multi-protein biomarker profile and real-world disability in multiple sclerosis
Zhu W., Chen C., Zhang L. et al.
Olink Focus
Communications Biology, 2023Identification of circulating proteins associated with general cognitive function among middle-aged and older adults
Tin A., Fohner A., Yang Q. et al.
Olink Target 96
BMC Medicine, 2023Associations of ultra-processed food consumption, circulating protein biomarkers, and risk of cardiovascular disease
Li H., Wang Y., Sonestedt E. et al.
Kidney International Reports, 2023Proteome-Wide Changes in Blood Biomarkers During Hemodialysis
Lanktree M., Collister D., Pigyere M. et al.
Kidney Medicine, 2023Protein Biomarkers and Major Cardiovascular Events in Older People With Advanced CKD: The European Quality (EQUAL) Study
Hayward S., Chesnaye N., Hole B. et al.
Cell Reports Medicine, 2023Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese
Jia X., Song E., Liu Y. et al.
Clinical and Translational Allergy, 2023Inflammatory related plasma proteins involved in acute preschool wheeze
Holmdahl I., Chakraborty S., Hoyer A. et al.
Clinical Immunology, 2023In-depth immune profiling reveals advanced B- and T-cell differentiation to be associated with Th1-driven immune dysregulation in common variable immunodeficiency
Hultberg J., Blixt E., Göransson R. et al.
Molecular Psychiatry, 2023Mitochondrial hypermetabolism precedes impaired autophagy and synaptic disorganization in App knock-in Alzheimer mouse models
Naia L., Shimozawa M., Bereczki E. et al.
Olink Target 96 Mouse
Biomedicine & Pharmacotherapy, 2023Decoding clinical and molecular pathways of liver dysfunction in Psoriatic Arthritis: Impact of cumulative methotrexate doses
Ruiz-Ponce M., Cuesta-López L., López-Montilla M. et al.
Nature Communications, 2023Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis
Åkesson J., Hojjati S., Hellberg S. et al.
Olink Explore 3072/384
Journal of the American Heart Association, 2023Proteomics and Precise Exercise Phenotypes in Heart Failure With Preserved Ejection Fraction: A Pilot Study
Shah R., Hwang S., Murthy V. et al.
Annals of Nutrition and Metabolism, 2023Screening for Inflammatory Markers Identifies IL-18Rα as a Potential Link between Exenatide and Its Anti-Inflammatory Effect: New Results from the Combat-JUDO Randomized Controlled Trial
Stenlid R., Cerenius S., Manell H. et al.
Nature Genetics, 2023Rare variants with large effects provide functional insights into the pathology of migraine subtypes, with and without aura
Bjornsdottir G., Chalmer M., Stefansdottir L. et al.
Journal of Neurology, Neurosurgery & Psychiatry, 2023Proximity extension assay-based discovery of biomarkers for disease activity in chronic inflammatory demyelinating polyneuropathy
Wieske L., Michael M., in 't Veld S. et al.
Journal of Investigative Dermatology, 2023Alterations to the Hidradenitis Suppurativa Serum Proteome with Spleen Tyrosine Kinase Antagonism: Proteomic Results from a Phase 2 Clinical Trial
Flora A., Jepsen R., Pham J. et al.
Journal of Clinical Medicine, 2023Cerebrospinal Fluid Proteomic Changes after Nusinersen in Patients with Spinal Muscular Atrophy
Beaudin M., Kamali T., Tang W. et al.
Biomedicine & Pharmacotherapy, 2023Angiotensin-converting enzyme inhibitors and statins therapies-induced changes in omics profiles in humans and transgenic tau mice
Collu R., Giunti E., Daley S. et al.
Translational Psychiatry, 2023Multivariate analyses of immune markers reveal increases in plasma EN-RAGE in first-episode psychosis patients
Korhonen L., Paul E., Wåhlén K. et al.
Critical Care Explorations, 2023Validating a Proteomic Signature of Severe COVID-19
Cosgriff C., Miano T., Mathew D. et al.
1889 publications
Items per page
361-380 of 1889 publications